SBWire

Mitchell, Goff & Mitchell provides Dallas-area clients with exceptional representation when it comes to wrongful death and catastrophic injury cases. In many instances, those affected by wrongful death or victims of catastrophic injuries require compensation to help them pay medical bills or supplement the loss of income. However, these personal injury cases also tend to be some of the most complex. The law partners of Mitchell, Goff & Mitchell specialize in these types of difficult cases and fight on behalf of their clients.

Those wild critters can be very cute, but when they enter your home, you want them out immediately. When there are strange noises coming from the attic or from between the walls, professional animal or pest control is absolutely necessary. Now, U.S. Wildlife Specialists, one of the leading animal control providers, offers animal and pest control services nation-wide. U.S. Wildlife Specialists’ professional animal control service includes humane wildlife removal and relocation back to their natural habitat.

EZCorporateClothing.com has added even more great and well known brands to their high quality clothing collection, offering businesses and organizations of all kinds a huge range of fantastic options when seeking personalized corporate or leisure shirts with both screen printing and embroidery.

Global Markets Direct's, 'Non-Hodgkin Lymphoma - Pipeline Review, H2 2012', provides an overview of the Non-Hodgkin Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Non-Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non-Hodgkin Lymphoma. 'Non-Hodgkin Lymphoma - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Paralysis - Pipeline Review, H2 2012', provides an overview of the Paralysis therapeutic pipeline. This report provides information on the therapeutic development for Paralysis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Paralysis. 'Paralysis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Chronic Bronchitis - Pipeline Review, H2 2012', provides an overview of the Chronic Bronchitis therapeutic pipeline. This report provides information on the therapeutic development for Chronic Bronchitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Bronchitis. 'Chronic Bronchitis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Other Bacterial Infections - Pipeline Review, H2 2012', provides an overview of the Other Bacterial Infections therapeutic pipeline. This report provides information on the therapeutic development for Other Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Bacterial Infections. 'Other Bacterial Infections - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's pharmaceuticals report, "Helix BioMedix, Inc. - Product Pipeline Review - 2012" provides data on the Helix BioMedix, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report comprises of high level market research data on the Finland beer industry, published by Canadean. The report covers total market (on- and off-premise) and includes valuable insight and analysis on beer market trends, brands, brewers, packaging, distribution channels, market valuation and pricing.

The report provides data, analyses and opinion to help companies in the retail industry better understand the changes in their environment, seize opportunities and formulate crucial business strategies.

This report presents detailed data on the cost sector in the Swiss foodservice industry through in-depth analysis of key channel trends, market size, historical and forecast sales data. The report examines the components of change in the channel with a focus on historic and future growth patterns.

Sustained economic growth has benefited Filipino consumers. With rising incomes and growing aspirations, Filipinos continue to spend and generate demand for a wide variety of consumer goods and services. Poverty, however, remains a concern in rural areas. Among other things, in coming years Filipino consumers are looking forward to lower inflation, less corruption and greater investment in infrastructure.

This analysis evaluates the company's strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company's biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development such as clinical trials (where available) for each key biosimilar molecule in development.

The asthma market has seen strong growth, with increased uptake of relatively expensive combination products. This trend is expected to change in the near future as sales growth will slow, and even turn negative, as key products face generic entry. However, by 2021, Datamonitor forecasts a return to positive growth such that the market will maintain value, with a CAGR over 2012-21 of 0.1%.

The rising incidence of cancer is continuing to drive intense R&D interest in oncology. Drug developers are shifting their attention towards the development of novel therapies for molecularly defined patient populations. The future will increasingly see the approval of targeted therapies for specific molecular aberrations and the incorporation of companion diagnostics in routine clinical practice.

The Vietnamese personal accident and health insurance market is competitive, and is considered to be the fastest-growing insurance market in Vietnam due to the implementation of compulsory health insurance by the Vietnamese government. The segment grew at a CAGR of XX% during the forecast period, the highest among all the three insurance segments. Rising disposable consumer income, government regulations and significant rises in medical expenditure are creating strong growth opportunities in the Vietnamese personal accident and health insurance segment. Multinational companies have started make their presence felt through aggressive pricing strategies, innovative distribution systems, and the absence of regulatory restrictions. Vietnamese government policy does not impose any strict regulations on foreign companies, which can operate in various forms such as joint ventures with Vietnamese companies, joint-stock companies, or fully owned enterprises.

This report is a thorough analysis of the Indonesian Wealth Management and Private Banking sector, and the opportunities and challenges that it faces.

Oil & Gas - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Oil & Gas industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Global Markets Direct's new report, "Greece Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" provides key market data on the Greece Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Global Market Direct's pharmaceuticals report, "Destiny Pharma Ltd. - Product Pipeline Review - 2012" provides data on the Destiny Pharma Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Vical Incorporated - Product Pipeline Review - 2012" provides data on the Vical Incorporated's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Trillium Therapeutics Inc. - Product Pipeline Review - 2012" provides data on the Trillium Therapeutics Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2012" provides data on the Tetraphase Pharmaceuticals Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

GlobalData’s ‘Nuclear Power Market Outlook in Germany to 2025, 2012 Update - Capacity, Generation, Regulations, Power Plants, Companies’ report deals with the nuclear power market analysis including energy mix, nuclear capacity and generation forecast, drivers, restraints key players, regulations, trends and developments in nuclear power industry. The report discusses in detail about the present energy mix and historic and forecast data for the nuclear installed capacity and generation. The forecast is done for the years 2012–2025. It also discusses about the regulatory framework which includes nuclear policy and regulations in the country. The report also includes the details of all reactors in the country and key players in nuclear industry.

EDP Energias de Portugal SA Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “EDP Energias de Portugal SA”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business structure, operations and products, and provides an analysis of its key revenue lines.